In Vitro Diagnostics Market, By Product & Service (Reagents & Kits, Instruments, and Data Management Software & Services), By Technology, By Specimen, By Site of Testing, By Application, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
REPORT HIGHLIGHT
In Vitro Diagnostics Market size was valued at USD 101,092.17 Million in 2024, expanding at a CAGR of 6.99% from 2024 to 2032.
In Vitro Diagnostics (IVD) refers to medical tests performed on samples such as blood, urine, or tissue taken from the human body. These tests are conducted outside the body, typically in laboratories, using specialized instruments and reagents. IVDs play a vital role in disease prevention, diagnosis, and monitoring by providing critical information that supports clinical decision-making. Common examples of IVD tools include blood glucose meters, pregnancy tests, and COVID-19 diagnostic kits. The accuracy and reliability of IVD tests are essential to ensuring effective healthcare outcomes and enabling personalized treatment strategies for a wide range of medical conditions.
In Vitro Diagnostics Market- Market Dynamics
Rising Prevalence of Chronic Diseases
The rising incidence of chronic diseases such as diabetes, cancer, and cardiovascular disorders is a key driver of growth in the in vitro diagnostics (IVD) market. These conditions require early detection and ongoing monitoring, increasing the demand for accurate and timely diagnostic solutions. Factors such as aging populations and lifestyle-related health issues further contribute to the global disease burden. IVD tests play a critical role in helping healthcare providers diagnose illnesses at early stages, monitor disease progression, and evaluate the effectiveness of treatments. This growing need for efficient and reliable diagnostic tools is fueling market expansion and driving investment and innovation in advanced IVD technologies.
Governments around the world are actively supporting this growth through targeted investments and policies. For example, the European Commission allocated approximately €190.9 million in 2022 to support projects like the AGLYC Project, which focuses on early detection biomarkers for cardiovascular diseases. In the United States, the Food and Drug Administration (FDA) approved over 100 new IVD devices in 2023, reflecting a strong regulatory push for innovation in diagnostics. Similarly, Japan\'s Global Health Innovative Technology (GHIT) Fund, backed by the Japanese government and global partners, continues to finance the development of advanced diagnostic tools for use in low- and middle-income countries. These global initiatives underscore the crucial role of government support in expanding access to diagnostic technologies and addressing the rising burden of chronic diseases.
In Vitro Diagnostics Market- Segmentation Analysis:
The global In Vitro Diagnostics Market is divided into seven categories: Product & Service, Technology, Specimen, Site of Testing, Application, End User and Region.
The in vitro diagnostics (IVD) market, when segmented by product and service, includes Reagents & Kits, Instruments, and Data Management Software & Services. Among these, Reagents & Kits hold the dominant share of the market. This strong position is largely attributed to their frequent and repetitive use in diagnostic procedures, which fuels constant demand across clinical laboratories, hospitals, and diagnostic centers. These reagents and kits form the backbone of most IVD platforms, playing a critical role in the accurate detection and quantification of various biomarkers and analytes. The increasing prevalence of infectious diseases, chronic health conditions, and the growing emphasis on personalized medicine have significantly accelerated the demand for high-quality, targeted reagents and test kits. Their indispensable role in delivering diagnostic accuracy, reliability, and convenience continues to reinforce their market dominance over instruments and software-based solutions. According to data from the U.S. Food and Drug Administration (FDA), reagents and kits make up more than 60% of all IVD products approved for use, reflecting their central importance in the diagnostic process.
In terms of technology, the IVD market is segmented into Immunoassays, Clinical Chemistry, Molecular Diagnostics, Glucose Monitoring, Hematology, Microbiology, Coagulation & Hemostasis, Blood Gas Analyzers, Urinalysis, and Chromatography & Mass Spectrometry. Immunoassays stand out as the dominant technological segment, owing to their broad utility in detecting infectious diseases, cancer biomarkers, autoimmune disorders, and hormonal imbalances. These assays are prized for their high sensitivity, specificity, and suitability for high-throughput testing environments, making them a mainstay in both centralized laboratories and point-of-care testing scenarios. The heightened need for rapid and precise diagnostic tools—especially highlighted during global health emergencies such as the COVID-19 pandemic—has further boosted the adoption of immunoassay technologies. Their adaptability to automated platforms and ability to target a wide array of analytes also contribute significantly to their leading position. According to the World Health Organization (WHO), over 70% of health care decisions worldwide rely on laboratory diagnostic results, and immunoassays play a central role in this framework, particularly in infectious disease diagnostics and oncology.
In Vitro Diagnostics Market- Geographical Insights
The global In Vitro Diagnostics (IVD) market is geographically distributed across North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. Each region contributes to the market based on varying degrees of healthcare infrastructure, economic development, disease prevalence, and regulatory frameworks.
North America holds a dominant position in the global IVD market, primarily driven by advanced healthcare infrastructure, high healthcare expenditure, and early adoption of cutting-edge diagnostic technologies. The United States is the leading contributor, supported by the presence of major market players, a robust regulatory framework (e.g., FDA approvals), and strong investment in research and development. The high prevalence of chronic diseases such as diabetes, cancer, and cardiovascular conditions further drives the demand for early and accurate diagnostic solutions. Additionally, well-established reimbursement policies and strong public awareness of preventive healthcare promote market growth. The increasing use of point-of-care testing and personalized medicine, along with the integration of digital health technologies, continues to strengthen North America’s leadership in the IVD market.
Europe is another key region in the global IVD landscape, bolstered by well-established healthcare systems, proactive government initiatives, and a growing elderly population that faces a high burden of chronic diseases. Major contributors like Germany, France, and the United Kingdom play a vital role through their investments in healthcare innovation and infrastructure. The region benefits from widespread access to early diagnostic screening programs and strong public health awareness. Regulatory support, including CE marking for IVD products, facilitates the timely introduction of advanced diagnostic solutions. Furthermore, the shift toward decentralized testing—accelerated by the COVID-19 pandemic—has led to broader adoption of point-of-care and molecular diagnostics. With ongoing advancements in diagnostic technologies and a focus on value-based healthcare, Europe remains a critical driver of global IVD market growth.
In Vitro Diagnostics Market- Competitive Landscape:
The IVD market is highly competitive, dominated by key players such as Danaher, F. Hoffmann-La Roche Ltd, Abbott, Thermo Fisher Scientific Inc., and Illumina, Inc. These companies maintain a significant share of the global market through their advanced diagnostic platforms, comprehensive product portfolios, and strong innovation pipelines. Their strategic focus lies in expanding capabilities in high-growth areas such as molecular diagnostics, next-generation sequencing (NGS), and point-of-care testing. This is supported by substantial investments in research and development, as well as strategic mergers and acquisitions.
Other notable players, including bioMérieux, Sysmex Corporation, and QIAGEN, are also enhancing their market positions by focusing on region-specific expansions, developing disease-specific diagnostic solutions, and tapping into emerging markets.
Recent Developments:
- February 2022: CooperSurgical acquired Cook Medical\'s reproductive health business for USD 875 million, significantly expanding its capabilities in IVD-related areas and strengthening its portfolio in women’s health diagnostics.
- June 2023: Becton Dickinson (BD) sold its surgical and sterilization assets to STERIS plc, a strategic move aimed at sharpening its focus on the diagnostics segment and streamlining its core business operations.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL IN VITRO DIAGNOSTICS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- Danaher
- F. Hoffmann-La Roche Ltd
- Abbott
- Thermo Fisher Scientific Inc.
- Illumina, Inc
- Hologic, Inc.
- Bio-Rad Laboratories, Inc.
- Biomérieux
- Sysmex Corporation
- Revvity
- Becton, Dickinson And Company
- Agilent Technologies, Inc.
- Qiagen
- Grifols, S.A.
- Werfen
- Quidelortho Corporation
- Devyser
- Biosynex Sa
- Surmodics, Inc.
- Others
GLOBAL IN VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICE - MARKET ANALYSIS, 2019 - 2032
- Reagents & Kits
- Instruments
- Data Management Software & Services
GLOBAL IN VITRO DIAGNOSTICS MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2019 - 2032
- Immunoassays
- Enzyme-Linked Immunosorbent Assays (Elisa)
- Chemiluminescence Immunoassays
- Immunofluorescence Assays
- Rapid Tests
- Enzyme-Linked Immunospot Assays (Elispot)
- Western Blotting
- Other Immunoassay Technologies
- Clinical Chemistry
- Basic Metabolic Panels
- Liver Panels
- Renal Profiles
- Thyroid Function Profiles
- Electrolyte Panels
- Specialty Chemical Tests
- Molecular Diagnostics
- Polymerase Chain Reaction
- Isothermal Nucleic Acid Amplification Technology
- Dna Sequencing & Next-Generation Sequencing
- In Situ Hybridization
- Dna Microarrays
- Other Molecular Diagnostic Technologies
- Glucose Monitoring
- Hematology
- Microbiology
- Coagulation & Hemostasis
- Blood Gas Analyzers
- Urinalysis
- Chromatography & Mass Spectrometry
GLOBAL IN VITRO DIAGNOSTICS MARKET, BY SPECIMEN - MARKET ANALYSIS, 2019 - 2032
- Blood, Serum, And Plasma Specimens
- Saliva Specimens
- Urine Specimens
- Other Specimens
GLOBAL IN VITRO DIAGNOSTICS MARKET, BY SITE OF TESTING- MARKET ANALYSIS, 2019 - 2032
- Laboratory Tests
- Point-Of-Care Tests
GLOBAL IN VITRO DIAGNOSTICS MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032
- Infectious Diseases
- Oncology
- Endocrinology
- Cardiology
- Blood Screening
- Genetic Testing
- Autoimmune Diseases
- Allergy Diagnostics
- Drug Monitoring & Testing
- Bone & Mineral Disorders
- Coagulation Testing
- Blood Group Typing
- Other Applications
GLOBAL IN VITRO DIAGNOSTICS MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032
- Hospitals & Clinics
- Clinical Laboratories
- Blood Banks
- Home Care Settings
- Pharmaceutical & Biotechnology Companies
- Academic Institutes
- Other End Users
GLOBAL IN VITRO DIAGNOSTICS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
TABLE OF CONTENT
1. In Vitro DiagnosticsMarketOverview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. In Vitro DiagnosticsMarket Snippet by Product & Services
2.1.2. In Vitro DiagnosticsMarket Snippet by Technology
2.1.3. In Vitro DiagnosticsMarket Snippet by Specimen
2.1.4. In Vitro DiagnosticsMarket Snippet by Site of Testing
2.1.5. In Vitro DiagnosticsMarket Snippet by Application
2.1.6. In Vitro DiagnosticsMarket Snippet by End User
2.1.7. In Vitro DiagnosticsMarket Snippet by Country
2.1.8. In Vitro DiagnosticsMarket Snippet by Region
2.2. Competitive Insights
3. In Vitro DiagnosticsKey Market Trends
3.1. In Vitro DiagnosticsMarket Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. In Vitro DiagnosticsMarket Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. In Vitro DiagnosticsMarket Opportunities
3.4. In Vitro DiagnosticsMarket Future Trends
4. In Vitro DiagnosticsIndustry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. In Vitro DiagnosticsMarket: COVID-19 Impact Analysis
5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
5.2.1. Top Performing Segments
5.2.2. Marginal Growth Segments
5.2.3. Top Looser Segments
5.2.4. Marginal Loss Segments
6. In Vitro DiagnosticsMarketLandscape
6.1. In Vitro DiagnosticsMarket Share Analysis, 2023
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. In Vitro Diagnostics Market – By Product & Services
7.1. Overview
7.1.1. Segment Share Analysis, By Product & Services, 2023&2032 (%)
7.1.2. Reagents & Kits
7.1.3. Instruments
7.1.4. Data Management Software & Services
8. In Vitro Diagnostics Market – By Technology
8.1. Overview
8.1.1. Segment Share Analysis, By Technology, 2023&2032 (%)
8.1.2. Immunoassays
8.1.2.1. Enzyme-Linked Immunosorbent Assays (Elisa)
8.1.2.2. Chemiluminescence Immunoassays
8.1.2.3. Immunofluorescence Assays
8.1.2.4. Rapid Tests
8.1.2.5. Enzyme-Linked Immunospot Assays (Elispot)
8.1.2.6. Western Blotting
8.1.2.7. Other Immunoassay Technologies
8.1.3. Clinical Chemistry
8.1.3.1. Basic Metabolic Panels
8.1.3.2. Liver Panels
8.1.3.3. Renal Profiles
8.1.3.4. Thyroid Function Profiles
8.1.3.5. Electrolyte Panels
8.1.3.6. Specialty Chemical Tests
8.1.4. Molecular Diagnostics
8.1.4.1. Polymerase Chain Reaction
8.1.4.2. Isothermal Nucleic Acid Amplification Technology
8.1.4.3. DNA Sequencing & Next-Generation Sequencing
8.1.4.4. In Situ Hybridization
8.1.4.5. DNA Microarrays
8.1.4.6. Other Molecular Diagnostic Technologies
8.1.5. Glucose Monitoring
8.1.6. Hematology
8.1.7. Microbiology
8.1.8. Coagulation & Hemostasis
8.1.9. Blood Gas Analyzers
8.1.10. Urinalysis
8.1.11. Chromatography & Mass Spectrometry
9. In Vitro Diagnostics Market – By Specimen
9.1. Overview
9.1.1. Segment Share Analysis, By Specimen, 2023&2032 (%)
9.1.2. Blood, Serum, And Plasma Specimens
9.1.3. Saliva Specimens
9.1.4. Urine Specimens
9.1.5. Other Specimens
10. In Vitro Diagnostics Market – By Site of Testing
10.1. Overview
10.1.1. Segment Share Analysis, By Site of Testing, 2023&2032 (%)
10.1.2. Laboratory Tests
10.1.3. Point-Of-Care Tests
11. In Vitro Diagnostics Market – By Application
11.1. Overview
11.1.1. Segment Share Analysis, By Application, 2023&2032 (%)
11.1.2. Infectious Diseases
11.1.3. Oncology
11.1.4. Endocrinology
11.1.5. Cardiology
11.1.6. Blood Screening
11.1.7. Genetic Testing
11.1.8. Autoimmune Diseases
11.1.9. Allergy Diagnostics
11.1.10. Drug Monitoring & Testing
11.1.11. Bone & Mineral Disorders
11.1.12. Coagulation Testing
11.1.13. Blood Group Typing
11.1.14. Other Applications
12. In Vitro Diagnostics Market – ByEnd User
12.1. Overview
12.1.1. Segment Share Analysis, By Application, 2023&2032 (%)
12.1.2. Hospitals & Clinics
12.1.3. Clinical Laboratories
12.1.4. Blood Banks
12.1.5. Home Care Settings
12.1.6. Pharmaceutical & Biotechnology Companies
12.1.7. Academic Institutes
12.1.8. Other End Users
13. In Vitro Diagnostics Market– By Geography
13.1. Introduction
13.1.1. Segment Share Analysis, By Geography, 2023&2032 (%)
13.2. North America
13.2.1. Overview
13.2.2. In Vitro DiagnosticsKey Manufacturers in North America
13.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
13.2.4. North America Market Size and Forecast, By Product & Services, 2019 - 2032 (US$ Million)
13.2.5. North America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
13.2.6. North America Market Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
13.2.7. North America Market Size and Forecast, By Site of Testing, 2019 - 2032 (US$ Million)
13.2.8. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
13.2.9. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
13.2.10. U.S.
13.2.10.1. Overview
13.2.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
13.2.10.3. U.S. Market Size and Forecast, By Product & Services, 2019 - 2032 (US$ Million)
13.2.10.4. U.S. Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
13.2.10.5. U.S. Market Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
13.2.10.6. U.S. Market Size and Forecast, By Site of Testing, 2019 - 2032 (US$ Million)
13.2.10.7. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
13.2.10.8. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
13.2.11. Canada
13.2.11.1. Overview
13.2.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
13.2.11.3. Canada Market Size and Forecast, By Product & Services, 2019 - 2032 (US$ Million)
13.2.11.4. Canada Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
13.2.11.5. Canada Market Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
13.2.11.6. Canada Market Size and Forecast, By Site of Testing, 2019 - 2032 (US$ Million)
13.2.11.7. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
13.2.11.8. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
13.3. Europe
13.3.1. Overview
13.3.2. In Vitro DiagnosticsKey Manufacturers in Europe
13.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
13.3.4. Europe Market Size and Forecast, By Product & Services, 2019 - 2032 (US$ Million)
13.3.5. Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
13.3.6. Europe Market Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
13.3.7. Europe Market Size and Forecast, By Site of Testing, 2019 - 2032 (US$ Million)
13.3.8. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
13.3.9. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
13.3.10. Germany
13.3.10.1. Overview
13.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
13.3.10.3. Germany Market Size and Forecast, By Product & Services, 2019 - 2032 (US$ Million)
13.3.10.4. Germany Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
13.3.10.5. Germany Market Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
13.3.10.6. Germany Market Size and Forecast, By Site of Testing, 2019 - 2032 (US$ Million)
13.3.10.7. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
13.3.10.8. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
13.3.11. Italy
13.3.11.1. Overview
13.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
13.3.11.3. Italy Market Size and Forecast, By Product & Services, 2019 - 2032 (US$ Million)
13.3.11.4. Italy Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
13.3.11.5. Italy Market Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
13.3.11.6. Italy Market Size and Forecast, By Site of Testing, 2019 - 2032 (US$ Million)
13.3.11.7. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
13.3.11.8. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
13.3.12. United Kingdom
13.3.12.1. Overview
13.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
13.3.12.3. United Kingdom Market Size and Forecast, By Product & Services, 2019 - 2032 (US$ Million)
13.3.12.4. United Kingdom Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
13.3.12.5. United Kingdom Market Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
13.3.12.6. United Kingdom Market Size and Forecast, By Site of Testing, 2019 - 2032 (US$ Million)
13.3.12.7. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
13.3.12.8. United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
13.3.13. France
13.3.13.1. Overview
13.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
13.3.13.3. France Market Size and Forecast, By Product & Services, 2019 - 2032 (US$ Million)
13.3.13.4. France Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
13.3.13.5. France Market Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
13.3.13.6. France Market Size and Forecast, By Site of Testing, 2019 - 2032 (US$ Million)
13.3.13.7. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
13.3.13.8. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
13.3.14. Russia
13.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
13.3.14.2. Russia Market Size and Forecast, By Product & Services, 2019 - 2032 (US$ Million)
13.3.14.3. Russia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
13.3.14.4. Russia Market Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
13.3.14.5. Russia Market Size and Forecast, By Site of Testing, 2019 - 2032 (US$ Million)
13.3.14.6. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
13.3.14.7. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
13.3.15. Netherlands
13.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
13.3.15.2. Netherlands Market Size and Forecast, By Product & Services, 2019 - 2032 (US$ Million)
13.3.15.3. Netherlands Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
13.3.15.4. Netherlands Market Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
13.3.15.5. Netherlands Market Size and Forecast, By Site of Testing, 2019 - 2032 (US$ Million)
13.3.15.6. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
13.3.15.7. Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
13.3.16. Sweden
13.3.16.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
13.3.16.2. Sweden Market Size and Forecast, By Product & Services, 2019 - 2032 (US$ Million)
13.3.16.3. Sweden Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
13.3.16.4. Sweden Market Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
13.3.16.5. Sweden Market Size and Forecast, By Site of Testing, 2019 - 2032 (US$ Million)
13.3.16.6. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
13.3.16.7. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
13.3.17. Poland
13.3.17.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
13.3.17.2. Poland Market Size and Forecast, By Product & Services, 2019 - 2032 (US$ Million)
13.3.17.3. Poland Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
13.3.17.4. Poland Market Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
13.3.17.5. Poland Market Size and Forecast, By Site of Testing, 2019 - 2032 (US$ Million)
13.3.17.6. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
13.3.17.7. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
13.3.18. Rest of Europe
13.3.18.1. Overview
13.3.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
13.3.18.3. Rest of the Europe Market Size and Forecast, By Product & Services, 2019 - 2032 (US$ Million)
13.3.18.4. Rest of the Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
13.3.18.5. Rest of the Europe Market Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
13.3.18.6. Rest of the Europe Market Size and Forecast, By Site of Testing, 2019 - 2032 (US$ Million)
13.3.18.7. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
13.3.18.8. Rest of the EuropeMarket Size and Forecast, By End User, 2019 - 2032 (US$ Million)
13.4. Asia Pacific (APAC)
13.4.1. Overview
13.4.2. In Vitro DiagnosticsKey Manufacturers in Asia Pacific
13.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
13.4.4. Asia Pacific Market Size and Forecast, By Product & Services, 2019 - 2032 (US$ Million)
13.4.5. Asia Pacific Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
13.4.6. Asia Pacific Market Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
13.4.7. Asia Pacific Market Size and Forecast, By Site of Testing, 2019 - 2032 (US$ Million)
13.4.8. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
13.4.9. Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
13.4.10. India
13.4.10.1. Overview
13.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
13.4.10.3. India Market Size and Forecast, By Product & Services, 2019 - 2032 (US$ Million)
13.4.10.4. India Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
13.4.10.5. India Market Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
13.4.10.6. India Market Size and Forecast, By Site of Testing, 2019 - 2032 (US$ Million)
13.4.10.7. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
13.4.10.8. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
13.4.11. China
13.4.11.1. Overview
13.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
13.4.11.3. China Market Size and Forecast, By Product & Services, 2019 - 2032 (US$ Million)
13.4.11.4. China Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
13.4.11.5. China Market Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
13.4.11.6. China Market Size and Forecast, By Site of Testing, 2019 - 2032 (US$ Million)
13.4.11.7. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
13.4.11.8. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
13.4.12. Japan
13.4.12.1. Overview
13.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
13.4.12.3. Japan Market Size and Forecast, By Product & Services, 2019 - 2032 (US$ Million)
13.4.12.4. Japan Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
13.4.12.5. Japan Market Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
13.4.12.6. Japan Market Size and Forecast, By Site of Testing, 2019 - 2032 (US$ Million)
13.4.12.7. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
13.4.12.8. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
13.4.13. South Korea
13.4.13.1. Overview
13.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
13.4.13.3. South Korea Market Size and Forecast, By Product & Services, 2019 - 2032 (US$ Million)
13.4.13.4. South Korea Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
13.4.13.5. South Korea Market Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
13.4.13.6. South Korea Market Size and Forecast, By Site of Testing, 2019 - 2032 (US$ Million)
13.4.13.7. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
13.4.13.8. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
13.4.14. Australia
13.4.14.1. Overview
13.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
13.4.14.3. Australia Market Size and Forecast, By Product & Services, 2019 - 2032 (US$ Million)
13.4.14.4. Australia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
13.4.14.5. Australia Market Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
13.4.14.6. Australia Market Size and Forecast, By Site of Testing, 2019 - 2032 (US$ Million)
13.4.14.7. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
13.4.14.8. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
13.4.15. Thailand
13.4.15.1. Overview
13.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
13.4.15.3. Thailand Market Size and Forecast, By Product & Services, 2019 - 2032 (US$ Million)
13.4.15.4. Thailand Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
13.4.15.5. Thailand Market Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
13.4.15.6. Thailand Market Size and Forecast, By Site of Testing, 2019 - 2032 (US$ Million)
13.4.15.7. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
13.4.15.8. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
13.4.16. Indonesia
13.4.16.1. Overview
13.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
13.4.16.3. Indonesia Market Size and Forecast, By Product & Services, 2019 - 2032 (US$ Million)
13.4.16.4. Indonesia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
13.4.16.5. Indonesia Market Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
13.4.16.6. Indonesia Market Size and Forecast, By Site of Testing, 2019 - 2032 (US$ Million)
13.4.16.7. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
13.4.16.8. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
13.4.17. Philippines
13.4.17.1. Overview
13.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
13.4.17.3. PhilippinesMarket Size and Forecast, By Product & Services, 2019 - 2032 (US$ Million)
13.4.17.4. PhilippinesMarket Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
13.4.17.5. PhilippinesMarket Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
13.4.17.6. PhilippinesMarket Size and Forecast, By Site of Testing, 2019 - 2032 (US$ Million)
13.4.17.7. PhilippinesMarket Size and Forecast, By Application, 2019 - 2032 (US$ Million)
13.4.17.8. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
13.4.18. Rest of APAC
13.4.18.1. Overview
13.4.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
13.4.18.3. Rest of APAC Market Size and Forecast, By Product & Services, 2019 - 2032 (US$ Million)
13.4.18.4. Rest of APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
13.4.18.5. Rest of APAC Market Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
13.4.18.6. Rest of APAC Market Size and Forecast, By Site of Testing, 2019 - 2032 (US$ Million)
13.4.18.7. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
13.4.18.8. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
13.5. Latin America
13.5.1. Overview
13.5.2. In Vitro DiagnosticsKey Manufacturers in Latin America
13.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
13.5.4. Latin America Market Size and Forecast, By Product & Services, 2019 - 2032 (US$ Million)
13.5.5. Latin America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
13.5.6. Latin America Market Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
13.5.7. Latin America Market Size and Forecast, By Site of Testing, 2019 - 2032 (US$ Million)
13.5.8. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
13.5.9. Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
13.5.10. Brazil
13.5.10.1. Overview
13.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
13.5.10.3. Brazil Market Size and Forecast, By Product & Services, 2019 - 2032 (US$ Million)
13.5.10.4. Brazil Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
13.5.10.5. Brazil Market Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
13.5.10.6. Brazil Market Size and Forecast, By Site of Testing, 2019 - 2032 (US$ Million)
13.5.10.7. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
13.5.10.8. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
13.5.11. Mexico
13.5.11.1. Overview
13.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
13.5.11.3. Mexico Market Size and Forecast, By Product & Services, 2019 - 2032 (US$ Million)
13.5.11.4. Mexico Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
13.5.11.5. Mexico Market Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
13.5.11.6. Mexico Market Size and Forecast, By Site of Testing, 2019 - 2032 (US$ Million)
13.5.11.7. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
13.5.11.8. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
13.5.12. Argentina
13.5.12.1. Overview
13.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
13.5.12.3. Argentina Market Size and Forecast, By Product & Services, 2019 - 2032 (US$ Million)
13.5.12.4. Argentina Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
13.5.12.5. Argentina Market Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
13.5.12.6. Argentina Market Size and Forecast, By Site of Testing, 2019 - 2032 (US$ Million)
13.5.12.7. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
13.5.12.8. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
13.5.13. Colombia
13.5.13.1. Overview
13.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
13.5.13.3. Colombia Market Size and Forecast, By Product & Services, 2019 - 2032 (US$ Million)
13.5.13.4. Colombia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
13.5.13.5. Colombia Market Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
13.5.13.6. Colombia Market Size and Forecast, By Site of Testing, 2019 - 2032 (US$ Million)
13.5.13.7. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
13.5.13.8. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
13.5.14. Rest of LATAM
13.5.14.1. Overview
13.5.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
13.5.14.3. Rest of LATAM Market Size and Forecast, By Product & Services, 2019 - 2032 (US$ Million)
13.5.14.4. Rest of LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
13.5.14.5. Rest of LATAM Market Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
13.5.14.6. Rest of LATAM Market Size and Forecast, By Site of Testing, 2019 - 2032 (US$ Million)
13.5.14.7. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
13.5.14.8. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
13.6. Middle East and Africa
13.6.1. Overview
13.6.2. In Vitro DiagnosticsKey Manufacturers in Middle East and Africa
13.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
13.6.4. Middle East and Africa Market Size and Forecast, By Product & Services, 2019 - 2032 (US$ Million)
13.6.5. Middle East and Africa Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
13.6.6. Middle East and Africa Market Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
13.6.7. Middle East and Africa Market Size and Forecast, By Site of Testing, 2019 - 2032 (US$ Million)
13.6.8. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
13.6.9. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
13.6.10. Saudi Arabia
13.6.10.1. Overview
13.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
13.6.10.3. Saudi Arabia Market Size and Forecast, By Product & Services, 2019 - 2032 (US$ Million)
13.6.10.4. Saudi Arabia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
13.6.10.5. Saudi Arabia Market Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
13.6.10.6. Saudi Arabia Market Size and Forecast, By Site of Testing, 2019 - 2032 (US$ Million)
13.6.10.7. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
13.6.10.8. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
13.6.11. United Arab Emirates
13.6.11.1. Overview
13.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
13.6.11.3. United Arab Emirates Market Size and Forecast, By Product & Services, 2019 - 2032 (US$ Million)
13.6.11.4. United Arab Emirates Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
13.6.11.5. United Arab Emirates Market Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
13.6.11.6. United Arab Emirates Market Size and Forecast, By Site of Testing, 2019 - 2032 (US$ Million)
13.6.11.7. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
13.6.11.8. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
13.6.12. Israel
13.6.12.1. Overview
13.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
13.6.12.3. IsraelMarket Size and Forecast, By Product & Services, 2019 - 2032 (US$ Million)
13.6.12.4. IsraelMarket Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
13.6.12.5. IsraelMarket Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
13.6.12.6. IsraelMarket Size and Forecast, By Site of Testing, 2019 - 2032 (US$ Million)
13.6.12.7. IsraelMarket Size and Forecast, By Application, 2019 - 2032 (US$ Million)
13.6.12.8. IsraelMarket Size and Forecast, By End User, 2019 - 2032 (US$ Million)
13.6.13. Turkey
13.6.13.1. Overview
13.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
13.6.13.3. Turkey Market Size and Forecast, By Product & Services, 2019 - 2032 (US$ Million)
13.6.13.4. Turkey Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
13.6.13.5. Turkey Market Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
13.6.13.6. Turkey Market Size and Forecast, By Site of Testing, 2019 - 2032 (US$ Million)
13.6.13.7. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
13.6.13.8. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
13.6.14. Algeria
13.6.14.1. Overview
13.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
13.6.14.3. Algeria Market Size and Forecast, By Product & Services, 2019 - 2032 (US$ Million)
13.6.14.4. Algeria Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
13.6.14.5. Algeria Market Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
13.6.14.6. Algeria Market Size and Forecast, By Site of Testing, 2019 - 2032 (US$ Million)
13.6.14.7. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
13.6.14.8. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
13.6.15. Egypt
13.6.15.1. Overview
13.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
13.6.15.3. Egypt Market Size and Forecast, By Product & Services, 2019 - 2032 (US$ Million)
13.6.15.4. Egypt Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
13.6.15.5. Egypt Market Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
13.6.15.6. Egypt Market Size and Forecast, By Site of Testing, 2019 - 2032 (US$ Million)
13.6.15.7. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
13.6.15.8. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
13.6.16. Rest of MEA
13.6.16.1. Overview
13.6.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
13.6.16.3. Rest of MEA Market Size and Forecast, By Product & Services, 2019 - 2032 (US$ Million)
13.6.16.4. Rest of MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
13.6.16.5. Rest of MEA Market Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
13.6.16.6. Rest of MEA Market Size and Forecast, By Site of Testing, 2019 - 2032 (US$ Million)
13.6.16.7. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
13.6.16.8. Rest of MEAMarket Size and Forecast, By End User, 2019 - 2032 (US$ Million)
14. Key Vendor Analysis- In Vitro Diagnostics Industry
14.1. Competitive Dashboard
14.2. Company Profiles
14.2.1. Danaher
14.2.2. F. Hoffmann-La Roche Ltd
14.2.3. Abbott
14.2.4. Thermo Fisher Scientific Inc.
14.2.5. Illumina, Inc
14.2.6. Hologic, Inc.
14.2.7. Bio-Rad Laboratories, Inc.
14.2.8. Biomérieux
14.2.9. Sysmex Corporation
14.2.10. Revvity
14.2.11. Becton, Dickinson And Company
14.2.12. Agilent Technologies, Inc.
14.2.13. Qiagen
14.2.14. Grifols, S.A.
14.2.15. Werfen
14.2.16. Quidelortho Corporation
14.2.17. Devyser
14.2.18. Biosynex Sa
14.2.19. Surmodics, Inc.
14.2.20. Others
15. 360 Degree AnalystView
16. Appendix
16.1. Research Methodology
16.2. References
16.3. Abbreviations
16.4. Disclaimer
16.5. Contact Us
